How to re-shape a transcatheter heart valve.

Brott TG, Cohen DJ, Cutlip DE, Van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation. Eur Heart J 2012;33:2403–2418. 11. Latib A, Naim C, De Bonis M, Sinning JM, Maisano F, Barbanti M, Parolari A, Lorusso R, Testa L, Actis Dato G, Miceli A, Sponga S, Rosato F, De Vincentiis C, Werner N, Fiorina C, Bartorelli A, Di Gregorio O, Casilli F, Muratori M, Alamanni F, Glauber M, Livi U, Nickenig G, Tamburino C, Alfieri O, Colombo A. Transcatheter aortic valve implantation—associated prosthetic valve infective endocarditis—results of a large multicenter registry. J Am Coll Cardiol 2014;64: 2176–2178. 12. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD. 2014 AHA/ ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438–88. 13. Hammerstingl C, Nickenig G, Grube E. Treatment of a degenerative stenosed CoreValve aortic bioprosthesis by transcatheter valve-in-valve insertion. Catheter Cardiovasc Interv 2011;79:748–755. 14. Sinning JM, Vasa-Nicotera M, Werner N, Zimmer S, Mellert F, Welz A, Grube E, Nickenig G, Hammerstingl C. CoreValve degeneration with severe transvalvular aortic regurgitation treated with valve-in-valve implantation. JACC Cardiovasc Interv 2014;7: e71–2. 15. Sinning JM, Vasa-Nicotera M, Chin D, Hammerstingl C, Ghanem A, Bence J, Kovac J, Grube E, Nickenig G, Werner N. Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol 2013;62: 11–20.